scholarly journals Clinical guidelines on arterial hypertension diagnosis, treatment and prevention in children and adolescents

2020 ◽  
Vol 17 (2) ◽  
pp. 7-35
Author(s):  
A. A. Aleksandrov ◽  
O. A. Kisliak ◽  
I. V. Leontyeva

Cardiovascular diseases (CVD) occupy a leading place in the structure of non-infectious pathology in adults and are the main cause of early disability and premature death in most economically developed countries. According to recent epidemiological studies, there has been a significant increase in both high normal blood pressure (BP) and arterial hypertension (AH) among children and adolescents. This applies to the greatest extent to adolescent children, while AH is detected from 4 to 22% of those surveyed, depending on the age of the surveyed and the selected criteria.

Author(s):  
Noemi M. Atucha ◽  
Paola Romecín ◽  
Felix Vargas ◽  
Joaquin García-Estañ

: Flavonoids are a class of substances of a vegetal origin with many interesting actions from the point of view of human disease. Interest in flavonoids in the diet has increased in recent years due to the publication of basic, clinical and epidemiological studies that have shown a whole array of salutory effects related to intake of flavonols and flavones as well as a lower morbility and mortality of cardiovascular diseases. Since arterial hypertension is the most common modifiable risk factor for cardiovascular diseases, this review will focus mainly on the effects of flavonoids on the cardiovascular system with relation to the elevation of blood pressure. Its antihypertensive effects as well as the many investigations performed in experimental models of arterial hypertension are reviewed in this mini-review.


2015 ◽  
Vol 96 (6) ◽  
pp. 994-999
Author(s):  
A A Agayev

Aim. To evaluate the significance of risk factors correction for treatment effectiveness improvement and prevention of arterial hypertension in outpatient conditions. Methods. The study was conducted in two phases over the period of 2011-2015 in Baku outpatient clinics. At the beginning of the first part of work 547 patients with controlled hypertension were followed up, by the end of study 437 patients remained followed up, 196 men and 241 women, aged from 23 to 68 years, disease duration was from 4 months to 14 years. At the beginning of the second part of the study measures for hypertension prevention were taken in 916 patients with normal blood pressure (788 patients completed the study). Results. In patients with long-term course of the disease, maintaining a stable target blood pressure (


2021 ◽  
Vol 93 (9) ◽  
pp. 1125-1131
Author(s):  
Valery I. Podzolkov ◽  
Anna Е. Bragina ◽  
Yulia N. Rodionova ◽  
Galina I. Bragina ◽  
Ekaterina E. Bykova

Results of foreign and Russian studies indicate a higher mortality rate of patients with concomitant cardiovascular diseases (CVD) due to the new coronavirus infection COVID-19. It has been proven that arterial hypertension, as one of the significant risk factors for the development of concomitant cardiovascular diseases, is associated with a more severe prognosis of COVID-19. This article presents the results of modern studies and large meta-analyzes of necessity and safety of the use of blockers of the renin-angiotensin-aldosterone system in patients with arterial hypertension and COVID-19. The data of studies show that an angiotensin-converting enzyme inhibitor (ACE inhibitor) and a thiazide-like diuretic is a pathogenetically rational combination. It realizes various ways of lowering blood pressure by reducing the activity of the renin-angiotensin-aldosterone system, which is achieved by using an ACE inhibitor, and natriuresis due to diuretics. As an example, a highly effective fixed combination of drugs is considered, characterized by good tolerance, which consists of an ACE inhibitor lisinopril and a thiazide-like diuretic indapamide of prolonged action. The authors expressed the opinion that the appointment of the fixed combination drug Diroton Plus (Gedeon Richter) will contribute to effective control of blood pressure and organoprotection in conditions of increased thrombogenic and prooxidative potential, characteristic of COVID-19 both in the acute stage and within the post-COVID Syndrome.


2018 ◽  
Vol 36 (Supplement 1) ◽  
pp. e250
Author(s):  
P. Skrzypczyk ◽  
K. Dziedzic-Jankowska ◽  
A. Ofiara ◽  
M. Szyszka ◽  
M. Panczyk-Tomaszewska

Author(s):  
V. F Luk’janov ◽  
Yuri Mikhailovich Raigorodskiy ◽  
N. V Bolotova ◽  
N. V Posokhova

The study included 90 patients with obesity I-III and arterial hypertension (AH) I of 16-30 years. Evaluated lipid and carbohydrate metabolism, the condition of the autonomic nervous system, circadian blood pressure, pulse wave velocity in the aorta (PWV), and the effectiveness of the running magnetic field with the help of apparatus «MAGNETIC SIMPATOKOR» in order to reduce blood pressure (BP). The patients were divided into 2 groups: basic - 50 people who underwent magnetic simpatokorrektsiya and control - 40 people received placebo physiotherapy. According to a survey in the group allocated to two subgroups - 1A and 1B. Subgroup 1A amounted to 26 patients with hypersympathicotonia who at repeated definition SPV after simpatokorrektsii noted its significant reduction. In the subgroup 1B included 24 patients with a normal tone and parasimpatikotoniey who SPV has not changed much. After 6 months in patients subgroups 1A BP was on normal numbers, DBS remained at baseline values. In the subgroup 1B patients remained elevated blood pressure. The risk of developing hypertension in a subgroup 1A was 22% in the subgroup 1B - 80% or more. Sympathy correction using magnetic field exposure on the cervical sympathetic ganglion is an effective treatment and prevention of hypertension associated with increased activity of the sympathetic nervous system.


2017 ◽  
Vol 28 (03) ◽  
pp. 321-332
Author(s):  
E. Asselmann ◽  
J. Venz ◽  
L. Pieper ◽  
H.-U. Wittchen ◽  
D. Pittrow ◽  
...  

Aims.Although associations between various somatic diseases and depression are well established, findings concerning the role of gender and anxiety disorders for these associations remain fragmented and partly inconsistent. Combining data from three large-scaled epidemiological studies in primary care, we aim to investigate interactions of somatic diseases with gender and anxiety disorders in the association with depression.Methods.Self-reported depression according to the International Classification of Diseases, Tenth Edition (ICD-10) was assessed in n = 83 737 patients from three independent studies [DETECT (Diabetes Cardiovascular Risk Evaluation: Targets and Essential Data for Commitment of Treatment), Depression-2000 and Generalized Anxiety and Depression in Primary Care (GAD-P)] using the Depression Screening Questionnaire (DSQ). Diagnoses of depression, anxiety disorders and somatic diseases were obtained from treating physicians via standardised clinical appraisal forms.Results.In logistic regressions, adjusted for gender, age group and study, each somatic disease except for arterial hypertension and endocrine diseases was associated with self-reported depression (odds ratio, OR 1.3–2.6) and each somatic disease was associated with physician-diagnosed depression (OR 1.1–2.4). Most of these associations remained significant after additional adjustment for anxiety disorders and other somatic diseases. The associations with depression increased with a higher number of somatic diseases. Cardiovascular diseases (OR 0.8), diabetes mellitus (OR 0.8) and neurological diseases (OR 0.8) interacted with gender in the association with self-reported depression, while endocrine diseases (OR 0.8) interacted with gender in the association with physician-diagnosed depression. That is, the associations between respective somatic diseases and depression were less pronounced in females v. males. Moreover, cardiovascular diseases (OR 0.7), arterial hypertension (OR 0.8), gastrointestinal diseases (OR 0.7) and neurological diseases (OR 0.6) interacted with anxiety disorders in the association with self-reported depression, and each somatic disease interacted with anxiety disorders in the association with physician-diagnosed depression (OR 0.6–0.8). That is, the associations between respective somatic diseases and depression were less pronounced in patients with v. without anxiety disorders; arterial hypertension was negatively associated with self-reported depression only in patients with anxiety disorders, but not in patients without anxiety disorders.Conclusions.A range of somatic diseases as well as anxiety disorders are linked to depression – and especially patients with co-/multi-morbidity are affected. However, interactions with gender and anxiety disorders are noteworthy and of relevance to potentially improve recognition and treatment of depression by physicians. Somatic diseases are associated more strongly with depression in males v. females as well as in patients without v. with anxiety disorders, primarily because women and patients with anxiety disorders per se are characterised by considerably increased depression prevalence that only marginally changes in the presence of somatic comorbidity.


2013 ◽  
Vol 12 (3) ◽  
pp. 85-88 ◽  
Author(s):  
E. Yu. Shupenina ◽  
E. N. Yushchuk ◽  
A. B. Khadzegova ◽  
S. V. Ivanova ◽  
I. A. Sadulaeva ◽  
...  

Cardiovascular disease (CVD) remains the leading cause of death in most developed countries. Morphological and functional status of large arteries plays an important role in the pathogenesis of CVD. At the moment, there are two main methods of aortic stiffness assessment: pulse wave velocity (PWV) measurement and central PW analysis. In advanced age, aortic stiffness increases, which manifests in increased PWV, elevated central blood pressure, and increased parameters of reflected PW. Similar changes can be observed in young patients with arterial hypertension. The existing evidence concerning obesity effects on aortic stiffness is contradictory and warrants further clarification. 


Sign in / Sign up

Export Citation Format

Share Document